INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V909. A total of 2 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $515,000 | -65.6% | 39,800 | -57.5% | 0.00% | -50.0% |
Q1 2016 | $1,497,000 | -2.6% | 93,600 | +74.3% | 0.00% | 0.0% |
Q4 2015 | $1,537,000 | +140.2% | 53,700 | +138.7% | 0.00% | +100.0% |
Q3 2015 | $640,000 | -61.4% | 22,500 | -51.3% | 0.00% | 0.0% |
Q2 2015 | $1,660,000 | +18.0% | 46,200 | +90.9% | 0.00% | 0.0% |
Q1 2015 | $1,407,000 | -16.2% | 24,200 | -39.2% | 0.00% | -50.0% |
Q4 2014 | $1,678,000 | -17.9% | 39,800 | -24.5% | 0.00% | 0.0% |
Q3 2014 | $2,044,000 | +619.7% | 52,700 | +479.1% | 0.00% | – |
Q2 2014 | $284,000 | – | 9,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 151,700 | $5,449,000 | 0.08% |
SIMPLEX TRADING, LLC | 90 | $95,000 | 0.01% |
Citadel Advisors | 46,200 | $1,660,000 | 0.00% |